Related Experiment Videos
Detection of psychoactive drugs using 19F MR spectroscopy
Journal of Neural Transmission. General Section
|January 1, 1995
Summary
Fluorine-19 (19F) Magnetic Resonance (MR) spectroscopy can now monitor brain drug levels. This technique, initially used in animal studies, shows promise for treating schizophrenia and depression in humans.
Area of Science:
- Neuroscience
- Pharmacology
- Medical Imaging
Background:
- In vivo 19F MR spectroscopy was first used in animal studies in 1983 to measure trifluorinated neuroleptics and antidepressants.
- Early experiments with rats involved long measurement times (up to 10 hours) for drugs like fluphenazine.
Purpose of the Study:
- To evaluate the potential of 19F MR spectroscopy as a tool for monitoring drug levels in the brain.
- To assess the feasibility of translating animal study findings to human applications for psychiatric conditions.
Main Methods:
- Utilized 19F MR spectroscopy for in vivo measurements.
- Employed surface coil techniques to improve signal-to-noise ratio and reduce measurement times.
- Conducted experiments in both animal models (rats) and human subjects.
Main Results:
- Significant improvements in signal-to-noise ratio and reduced measurement times (to minutes) were achieved with advanced techniques.
- Demonstrated the capability to detect and estimate brain levels of trifluorinated neuroleptics and antidepressants.
- Data from multiple research groups confirm the potential of 19F MR spectroscopy.
Conclusions:
- 19F MR spectroscopy is a promising tool for monitoring drug concentrations at the site of action.
- Translating animal studies to human applications could lead to improved treatment strategies for schizophrenic and depressive patients.